Minnesota SF1876 mandates pharmacy benefit managers and health carriers to include lower-cost drugs in their formularies and prioritize the lowest.

Minnesota SF1876 requires pharmacy benefit managers and health carriers to include lower-cost drugs in their formularies. Specifically, if a generic drug or biosimilar has a lower wholesale acquisition cost than existing drugs in the formulary, it must be added. The bill also mandates that formularies be structured to prioritize the drug with the lowest out-of-pocket cost to patients. It prohibits any prior authorization, step therapy, or other coverage limitations on the lowest-cost drug. This law aims to make essential medications more affordable and accessible to patients in Minnesota.

Minnesota SF1876 mandates pharmacy benefit managers and health carriers to include lower-cost drugs in their formularies and prioritize the lowest.

Minnesota SF1876 requires pharmacy benefit managers and health carriers to include lower-cost drugs in their formularies. Specifically, if a generic drug or biosimilar has a lower wholesale acquisition cost than existing drugs in the formulary, it must be added. The bill also mandates that formularies be structured to prioritize the drug with the lowest out-of-pocket cost to patients. It prohibits any prior authorization, step therapy, or other coverage limitations on the lowest-cost drug. This law aims to make essential medications more affordable and accessible to patients in Minnesota.